N Nishimura Selected Research

N Nishimura Research Topics

Disease

6	Neoplasms (Cancer) 03/2010 - 01/2001
3	Lung Neoplasms (Lung Cancer) 11/2001 - 01/2001
3	Body Weight (Weight, Body) 08/2001 - 03/2001
2	Leukemia 01/2005 - 02/2001
2	Hyperplasia 05/2003 - 06/2001
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2017
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2017
1	Mumps 01/2014
1	Rubella (German Measles) 01/2014
1	Chickenpox 01/2014
1	Measles 01/2014
1	Vaccine-Preventable Diseases 01/2014
1	Bone Resorption 12/2010
1	Inflammation (Inflammations) 03/2010
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 06/2008
1	Pneumonia (Pneumonitis) 06/2008
1	Systemic Scleroderma (Systemic Sclerosis) 08/2005
1	Necrosis 08/2005
1	Infections 01/2005
1	Ulcerative Colitis 10/2004
1	Headache (Headaches) 10/2004
1	Hemorrhage 10/2004
1	Abdominal Pain (Pain, Abdominal) 10/2004
1	Fever (Fevers) 10/2004
1	Liver Diseases (Liver Disease) 10/2004
1	Asthma (Bronchial Asthma) 07/2003
1	Pathologic Constriction (Stenosis) 09/2001
1	Coronary Artery Disease (Coronary Atherosclerosis) 09/2001
1	Breast Neoplasms (Breast Cancer) 07/2001
1	Endometrial Neoplasms (Endometrial Cancer) 07/2001
1	Hyperinsulinism (Hyperinsulinemia) 05/2001
1	Hyperglycemia 05/2001
1	Obesity 05/2001
1	Dehydration (Water Stress) 03/2001
1	Pheochromocytoma 02/2001
1	Colorectal Neoplasms (Colorectal Cancer) 02/2001
1	Colonic Neoplasms (Colon Cancer) 02/2001
1	Neoplasm Metastasis (Metastasis) 01/2001
1	Congenital Abnormalities (Deformity) 12/2000
1	Pseudarthrosis (Pseudoarthrosis) 12/2000
1	Contact Dermatitis (Eczema, Contact) 07/2000
1	Exanthema (Rash) 05/2000

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2005 - 03/2001
3	Polychlorinated Dibenzodioxins (TCDD)IBA 05/2003 - 03/2001
2	EnzymesIBA 01/2014 - 08/2005
2	VaccinesIBA 01/2014 - 05/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2005 - 01/2001
2	Complementary DNA (cDNA)IBA 10/2001 - 02/2001
1	Vincristine (Oncovin)FDA LinkGeneric 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2017
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	AntibodiesIBA 01/2014
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2010
1	LeptinIBA 12/2010
1	deoxypyridinolineIBA 12/2010
1	PolyaminesIBA 03/2010
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 06/2008
1	Proteins (Proteins, Gene)FDA Link 01/2005
1	Interleukin-12 (IL 12)IBA 07/2003
1	Thyroid HormonesIBA 05/2003
1	Nylons (Nylon)IBA 06/2002
1	InterleukinsIBA 11/2001
1	CytokinesIBA 11/2001
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2001
1	Phenobarbital (Luminal)FDA Link 09/2001
1	Tamoxifen FDA LinkGeneric 07/2001
1	8-Hydroxy-2'-DeoxyguanosineIBA 06/2001
1	DNA AdductsIBA 06/2001
1	Peptides (Polypeptides)IBA 05/2001
1	Glucose (Dextrose)FDA LinkGeneric 05/2001
1	Neuropeptide YIBA 05/2001
1	Sucrose (Saccharose)IBA 05/2001
1	Methylene Chloride (Dichloromethane)IBA 03/2001
1	AnhydridesIBA 03/2001
1	acetaldehyde oxime (acetaldoxime)IBA 03/2001
1	triethylamine (triethylamine hydrochloride)IBA 03/2001
1	TriazinesIBA 03/2001
1	Ouabain (G Strophanthin)IBA 02/2001
1	Messenger RNA (mRNA)IBA 02/2001
1	MetallothioneinIBA 02/2001
1	DNA (Deoxyribonucleic Acid)IBA 02/2001
1	beta CateninIBA 02/2001
1	Cyclin EIBA 02/2001
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2001
1	NF-kappa B (NF-kB)IBA 01/2001
1	Urocanic AcidIBA 07/2000
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2000

Therapy/Procedure

3	Immunotherapy 11/2001 - 03/2001
2	Therapeutics 01/2017 - 10/2004
1	Length of Stay 06/2008
1	Blood Component Removal (Apheresis) 10/2004
1	Stents 09/2001
1	Distraction Osteogenesis 12/2000
1	Bone Transplantation (Bone Grafting) 12/2000